Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayumi Idei

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 19, 2019
Bioimpedance Spectroscopy-Based Fluid Status in Combined Dialysis Compared With Hemodialysis and Peritoneal Dialysis: A Cross-Sectional StudyMototsugu Tanaka, Yoshitaka Ishibashi, Yoshifumi Hamasaki, et al.
Journal of Clinical Pathology|April 26, 2011
The use of CellaVision competency software for external quality assessment and continuing professional developmentYuki Horiuchi, Yoko Tabe, Mayumi Idei, et al.
Kidney International Reports|April 14, 2020
Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With HemodialysisMototsugu Tanaka, Yoshitaka Ishibashi, Yoshifumi Hamasaki, et al.
British Journal of Clinical Pharmacology|March 11, 2021
Achievements and challenges of the Sakigake designation system in JapanMototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, et al.
Clinical Pharmacology and Therapeutics|October 13, 2020
Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory AnalysisMototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 27, 2017
Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjectsKenta Sasamoto, Satoshi Hirayama, Mika Kon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2016
Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patientsMayumi Idei, Yoko Tabe, Chieko Hamada, et al.
British Journal of Clinical Pharmacology|January 29, 2021
Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in JapanMototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, et al.
Journal of Atherosclerosis and Thrombosis|June 5, 2010
Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levelsYuki Horiuchi, Satoshi Hirayama, Satoshi Soda, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
Health-related quality of life on combination therapy with peritoneal dialysis and hemodialysis in comparison with hemodialysis and peritoneal dialysis: A cross-sectional studyMototsugu Tanaka, Yoshitaka Ishibashi, Yoshifumi Hamasaki, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 19, 2019
Bioimpedance Spectroscopy-Based Fluid Status in Combined Dialysis Compared With Hemodialysis and Peritoneal Dialysis: A Cross-Sectional StudyMototsugu Tanaka, Yoshitaka Ishibashi, Yoshifumi Hamasaki, et al.
Journal of Clinical Pathology|April 26, 2011
The use of CellaVision competency software for external quality assessment and continuing professional developmentYuki Horiuchi, Yoko Tabe, Mayumi Idei, et al.
Kidney International Reports|April 14, 2020
Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With HemodialysisMototsugu Tanaka, Yoshitaka Ishibashi, Yoshifumi Hamasaki, et al.
British Journal of Clinical Pharmacology|March 11, 2021
Achievements and challenges of the Sakigake designation system in JapanMototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, et al.
Clinical Pharmacology and Therapeutics|October 13, 2020
Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory AnalysisMototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 27, 2017
Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjectsKenta Sasamoto, Satoshi Hirayama, Mika Kon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2016
Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patientsMayumi Idei, Yoko Tabe, Chieko Hamada, et al.
British Journal of Clinical Pharmacology|January 29, 2021
Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in JapanMototsugu Tanaka, Mayumi Idei, Hiroshi Sakaguchi, et al.
Journal of Atherosclerosis and Thrombosis|June 5, 2010
Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levelsYuki Horiuchi, Satoshi Hirayama, Satoshi Soda, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 18, 2020
Health-related quality of life on combination therapy with peritoneal dialysis and hemodialysis in comparison with hemodialysis and peritoneal dialysis: A cross-sectional studyMototsugu Tanaka, Yoshitaka Ishibashi, Yoshifumi Hamasaki, et al.
Pageof 3